Type 1 Diabetes Trial, Recruiting (NCT07317986)

Type 1 Diabetes Trial, Recruiting NCT07317986 Sponsor: Laval University Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07317986 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People living with Type 1 diabetes (T1D), or a rare form of diabetes that requires insulin, such as Latent Autoimmune Diabetes of Adults (LADA), Maturity-Onset Diabetes of the Young (MODY), or type 3c diabetes (which develops after an injury to or removal of the pancreas).
People who are a loved one of someone with T1D or one of the rarer insulin-requiring forms of diabetes mentioned above — for example, a parent, child, spouse, caregiver, or friend.
People who are 18 years of age or older.
People who live in Canada.
People who are able to read the consent form in either English or French.

Who may not be able to join:

People who have type 2 diabetes, pre-diabetes, or gestational diabetes, and who have no connection to T1D, LADA, MODY, type 3c, or another rare insulin-requiring form of diabetes.
People who are under 18 years old (note: the trial team has mentioned a hope to include younger participants in the future, pending ethics board approvals and appropriate consent processes — confirm with trial site for any updates).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 418-656-2131

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07317986

Sponsor: Laval University

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 418-656-2131

More information: https://clinicaltrials.gov/study/NCT07317986

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People living with Type 1 diabetes (T1D), or a rare form of diabetes that requires insulin, such as Latent Autoimmune Diabetes of Adults (LADA), Maturity-Onset Diabetes of the Young (MODY), or type 3c diabetes (which develops after an injury to or removal of the pancreas).
People who are a loved one of someone with T1D or one of the rarer insulin-requiring forms of diabetes mentioned above — for example, a parent, child, spouse, caregiver, or friend.
People who are 18 years of age or older.
People who live in Canada.
People who are able to read the consent form in either English or French.

Who may not be able to join:

People who have type 2 diabetes, pre-diabetes, or gestational diabetes, and who have no connection to T1D, LADA, MODY, type 3c, or another rare insulin-requiring form of diabetes.
People who are under 18 years old (note: the trial team has mentioned a hope to include younger participants in the future, pending ethics board approvals and appropriate consent processes — confirm with trial site for any updates).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Laval University

Registry

ClinicalTrials.gov

Start date

7 July 2025

Est. completion

1 July 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Diabetes Distress

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov